Insulin resistance, metabolic stress, and atherosclerosis

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 3, 2012, Pages 916-931

  Pansuria, Meghana ^a   Xi, Hang ^a   Li, Le ^a,b   Yang, Xiao Feng ^a   Wang, Hong ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Atherosclerosis; Diabetes; Insulin signaling; Review

Indexed keywords

INSULIN; INSULIN RECEPTOR;

ADIPOSE TISSUE; ARTICLE; ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; DYSLIPIDEMIA; ENDOTHELIUM CELL; HUMAN; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; IMMUNOCOMPETENT CELL; INSULIN RESISTANCE; LIVER; MACROPHAGE; METABOLIC STRESS; METABOLIC SYNDROME X; MONOCYTE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; SKELETAL MUSCLE; T LYMPHOCYTE; VASCULAR SMOOTH MUSCLE; ANIMAL; HYPERTENSION; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS; REVIEW;

ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; RECEPTOR, INSULIN; STRESS, PHYSIOLOGICAL;

EID: 84867766778     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (165)

1. D Porte, Jr.: Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40, 166-180 (1991)
2. R. Eckel, S. Grundy, P Z Zimmet: The metabolic syndrome. Lancet 365, 1415-1428 (2005) (Pubitemid 40523737)
3. American diabetes association. http://www.diabetes.org/diabetes-basics/ diabetes-statistics/(2011)
4. K. Petersen, G I Shulman: Etiology of insulin resistance. Am J Med 119, S10-S16 (2006)
5. Z. Jiang, Y. Lin, A Clemont. E P Feener, K. Hein, M Igarashi. T Yamauchi, M. White, G L King: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104, 447-457 (1999) (Pubitemid 29534329)
6. H. Steinberg, G Brechtel. A Johnson, N Fineberg, A D Baron: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invet 94, 1172-1179 (1994)
7. R Ross: Cell biology of atherosclerosis. Annu Rev Physiol 57, 791-804 (1995)
8. J Nigro. N Osman, A. Dart, P J Little: Insulin resistance and atherosclerosis. Endocr Rev 27, 242-259 (2006)
9. E. Feener, G L King: Vascular dysfunction in diabetes mellitus. Lancet 350 Suppl 1, SI9-SI13 (1997) (Pubitemid 27303531)
10. W. Hsueh, C. Lyon, M J Quinones: Insulin resistance and the endothelium. Am J Med 117, 109-17 (2004) (Pubitemid 38953731)
11. D Malide. T M Davies-Hill, M Levine, I A Simpson: Distinct localization of GLUT-1, -3, and -5 in human monocyte-derived macrophages: effects of cell activation. Am J Physiol 274, E516-E526 (1998)
12. A. Saltiel, C R Kahn: Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414, 799-806 (2001) (Pubitemid 34000783)
13. F. Nystrom, M J Quon: Insulin signaling: metabolic pathways and mechanisms for specificity. Cell Signal 11, 563-574 (1999) (Pubitemid 29255888)
14. WhiteMF: IRS proteins and the common path to diabetes. AmJ Physiol Endocrinol Metab 283, E413-E422 (2002) (Pubitemid 35230477)
15. P Gual. Y Le Marchand-Brustel, J F Tanti: Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99-109 (2005) (Pubitemid 40298772)
16. L. Qiao, R Zhande. T L Jetton, G Zhou, X J Sun: In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J Biol Chem 277, 26530-26539 (2002) (Pubitemid 34967150)
17. P. Shepherd, D. Withers, K Siddle: Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333(Pt 3), 471-490 (1998) (Pubitemid 28398511)
18. L C Cantley: The phosphoinositide 3-kinase pathway. Science 296, 1655-1657 (2002) (Pubitemid 34579158)
19. B Vanhaesebroeck, D R Alessi: The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 Pt 3, 561-576 (2000) (Pubitemid 30171014)
20. F. Scholl, P. Dumesic, D. Barragan, K Harada. V Bissonauth, J Charron, P A Khavari: Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia. Dev Cell 12, 615-629 (2007) (Pubitemid 46523646)
21. G. Johnson, R Lapadat: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912 (2002) (Pubitemid 35425238)
22. E. Wagner, A R Nebreda: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9, 537-549 (2009)
23. S Kumar. J Boehm, J C Lee: p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2, 717-726 (2003) (Pubitemid 37361787)
24. D G Hardie: Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144, 5179-5183 (2003) (Pubitemid 37476044)
25. H Chen. M Montagnani, T Funahashi. I Shimomura, M J Quon: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278, 45021-450216 (2003)
26. N Jessen. R Pold, E. Buhl, L. Jensen, O Schmitz, S Lund: Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 94, 1373-1379 (2003) (Pubitemid 36348812)
27. R Lage. C Dieguez, A Vidal-Puig, M Lopez: AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14, 539-549 (2008)
28. K Hojlund. K J Mustard, P Staehr. D G Hardie, H Beck-Nielsen. E A Richter, J F Wojtaszewski: AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes. Am J Physiol Endocrinol Metab 286, E239-E244 (2004) (Pubitemid 38140315)
29. G. Weir, S Bonner-Weir: Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53, Suppl 3, S16-21 (2004) (Pubitemid 39564517)
30. T Okada. C W Liew, J Hu. C Hinault, M. Michael, J Krtzfeldt. C Yin, M Holzenberger. M Stoffel, R N Kulkarni: Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A 104, 8977-8982 (2007) (Pubitemid 47175422)
31. R. Kulkarni, J. Bruning, J. Winnay, C Postic. M A Magnuson, C R Kahn: Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96, 329-339 (1999) (Pubitemid 29077587)
32. K Otani. R N Kulkarni, A. Baldwin, J Krutzfeldt. K Ueki, M Stoffel. C R Kahn, K S Polonsky: Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab 286, E41-E49 (2004) (Pubitemid 38036608)
33. G S Hotamisligil: Inflammation and metabolic disorders. Nature 444, 860-867 (2006) (Pubitemid 46024993)
34. Y Kajimoto, H Kaneto: Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci 1011, 168-176 (2004) (Pubitemid 38608402)
35. J Hirosumi. G Tuncman, L Chang. C Z Gorgun, K. Uysal, K Maeda. M Karin, G S Hotamisligil: A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002) (Pubitemid 35398190)
36. G Sumara. I Formentini, S Collins. I Sumara, R Windak. B Bodenmiller, R Ramracheya. D Caille, H Jiang. K A Platt, P Meda. R Aebersold, P Rorsman, R Ricci: Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell 136, 235-248 (2009)
37. K Maedler. J Storling, J Sturis. R A Zuellig, G. Spinas, P. Arkhammar, T Mandrup-Poulsen, M Y Donath: Glucoseand interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. Diabetes 53, 1706-1713 (2004) (Pubitemid 38857028)
38. M. Donath, D. Gross, E Cerasi, N Kaiser: Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48, 738-744 (1999) (Pubitemid 29153072)
39. M Federici. M Hribal, L Perego. M Ranalli, Z Caradonna. C Perego, L Usellini. R Nano, P Bonini. F Bertuzzi, L. Marlier, A. Davalli, O Carandente. A E Pontiroli, G Melino. P Marchetti, R Lauro. G Sesti, F Folli: High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50, 1290-1301 (2001) (Pubitemid 32500161)
40. A. Butler, J Janson. S Bonner-Weir, R Ritzel. R A Rizza, P C Butler: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110 (2003) (Pubitemid 36042113)
41. W El-Assaad. J Buteau, M. Peyot, C Nolan. R Roduit, S Hardy. E Joly, G Dbaibo. L Rosenberg, M Prentki: Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144, 4154-4163 (2003) (Pubitemid 37088771)
42. R Lupi. F Dotta, L Marselli. S Del Guerra, M Masini. C Santangelo, G Patane. U Boggi, S Piro. M Anello, E Bergamini. F Mosca, U D. Mario, S De. Prato, P Marchetti: Prolonged exposure to free fatty acids has cytostatic and proapoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51, 1437-1442 (2002) (Pubitemid 34826609)
43. S. Kahn, R. Hull, K M Utzschneider: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (2006) (Pubitemid 46024990)
44. S Piro. M Anello, C D. Pietro, M. Lizzio, G Patane. A M Rabuazzo, R Vigneri. M Purrello, F Purrello: Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51, 1340-1347 (2002) (Pubitemid 35174157)
45. H Yki-Jarvinen: Nonglycemic effects of insulin. Clin Cornerstone Suppl 4, S6-S12 (2003) (Pubitemid 38180825)
46. N Kubota. K Tobe, Y Terauchi. K Eto, T Yamauchi. R Suzuki, Y Tsubamoto. K Komeda, R Nakano. H Miki, S Satoh. H Sekihara, S Sciacchitano. M Lesniak, S Aizawa. R Nagai, S Kimura. Y Akanuma, S. Taylor, T Kadowaki: Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49, 1880-1889 (2000)
47. L Pirola. A M Johnston, E Van Obberghen: Modulation of insulin action. Diabetologia 47, 170-184 (2004) (Pubitemid 38315353)
48. G Boden. X Chen, J Ruiz. J V White, L Rossetti: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93, 2438-2446 (1994) (Pubitemid 24177157)
49. G Boden. P Cheung, T. Stein, K Kresge, M Mozzoli: FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283, E12-E19 (2002) (Pubitemid 34686662)
50. G Boden: Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 52, 375-378 (2004) (Pubitemid 39552606)
51. J Fruebis. T S Tsao, S Javorschi. D Ebbets-Reed, M. Erickson, F. Yen, B. Bihain, H F Lodish: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98, 2005-2010 (2001) (Pubitemid 32165613)
52. T Yamauchi. J Kamon, Y Minokoshi. Y Ito, H Waki. S Uchida, S Yamashita. M Noda, S Kita. K Ueki, K Eto. Y Akanuma, P Froguel. F Foufelle, P Ferre. D Carling, S Kimura. R Nagai, B. Kahn, T Kadowaki: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295 (2002) (Pubitemid 35373562)
53. A. Berg, T. Combs, X Du. M Brownlee, P E Scherer: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7, 947-953 (2001) (Pubitemid 32756433)
54. R. Avramoglu, H Basciano, K Adeli: Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 368, 1-19 (2006) (Pubitemid 43776015)
55. L Rossetti. A Giaccari, R A DeFronzo: Glucose toxicity. Diabetes Care 13, 610-630 (1990) (Pubitemid 20169143)
56. M Nawano. A Oku, K Ueta. I Umebayashi, T Ishirahara. K Arakawa, A Saito. M Anai, M Kikuchi, T Asano: Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab 278, E535-E543 (2000) (Pubitemid 30149399)
57. M. Pouwels, P. Span, C. Tack, A. Olthaar, C. Sweep, B. van Engelen, J. de Jong, J. Lutterman, A R Hermus: Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes. J Clin Endocrinol Metab 87, 5179-5184 (2002) (Pubitemid 35316362)
58. K. Lin, A Ito. T Asagami, P. Tsao, S Adimoolam. M Kimoto, H Tsuji. G M Reaven, J P Cooke: Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106, 987-92 (2002) (Pubitemid 34925335)
59. X. Du, D Edelstein. S Dimmeler, Q Ju. C Sui, M Brownlee: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108, 1341-1348 (2001) (Pubitemid 33107762)
60. B Schnyder. M Pittet, J Durand, S Schnyder-Candrian: Rapid effects of glucose on the insulin signaling of endothelial NO generation and epithelial Na transport. Am J Physiol Endocrinol Metab 282, E87-E94 (2002) (Pubitemid 34654111)
61. M Maytin. J Leopold, J Loscalzo: Oxidant stress in the vasculature. Curr Atheroscler Rep 1, 156-164 (1999)
62. M Brownlee: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615-1625 (2005) (Pubitemid 40770750)
63. M G Buse: Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290, E1-E8 (2006)
64. T Nishikawa. D Edelstein, X. Du, S Yamagishi. T Matsumura, Y Kaneda. M A Yorek, D Beebe. P J Oates, H. Hammes, I Giardino, M Brownlee: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790 (2000) (Pubitemid 30212409)
65. U Chakravarthy. R G Hayes, A. Stitt, E McAuley, D B Archer: Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 47, 945-952 (1998) (Pubitemid 28255670)
66. L. Ball, M. Berkaw, M G Buse: Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol Cell Proteomics 5, 313-23 (2006) (Pubitemid 43329309)
67. A. Baron, J. Zhu, J. Zhu, H Weldon. L Maianu, W T Garvey: Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 96, 2792-2801 (1995)
68. T Inoguchi. P Li, F Umeda. H Y Yu, M Kakimoto. M Imamura, T Aoki. T Etoh, T Hashimoto. M Naruse, H Sano. H Utsumi, H Nawata: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD (P) H oxidase in cultured vascular cells. Diabetes 49, 1939-1945 (2000)
69. K Kuboki. Z Y Jiang, N Takahara. S W Ha, M Igarashi. T Yamauchi, E. Feener, T. Herbert, C. Rhodes, G L King: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101, 676-6810 (2000)
70. G. King, M R Loeken: Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122, 333-338 (2004) (Pubitemid 39506591)
71. A Goldin. J A Beckman, A. Schmidt, M A Creager: Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 14, 597-605 (2006) (Pubitemid 44199649)
72. L. Wold, A. Ceylan-Isik, J Ren: Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 26, 908-917 (2005) (Pubitemid 41153210)
73. C Miele. A Riboulet, M. Maitan, F Oriente. C Romano, P Formisano. J Giudicelli, F Beguinot, E Van Obberghen: Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism. J Biol Chem 278, 47376-47387 (2003) (Pubitemid 37523177)
74. M. Wautier, O Chappey. S Corda, D. Stern, A. Schmidt, J L Wautier: Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280, E685-E694 (2001)
75. A. Schmidt, S. Yan, J. Wautier, D Stern: Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84, 489-497 (1999) (Pubitemid 29138585)
76. A Rojas. S Romay, D Gonzalez. B Herrera, R Delgado, K Otero: Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. Circ Res 86, E50-E54 (2000)
77. P Quehenberger. A Bierhaus, P Fasching. C Muellner, M Klevesath. M Hong, G Stier. M Sattler, E Schleicher. W Speiser, P P Nawroth: Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabete 49, 1561-1570 (2000)
78. G Boden, G I Shulman: Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 Suppl 3, 14-23 (2002) (Pubitemid 41704996)
79. G I Shulman: Cellular mechanisms of insulin resistance. J Clin Invest 106, 171-176 (2000) (Pubitemid 30483118)
80. P S Jellinger: Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 8 Suppl 7, S30-S42 (2007) (Pubitemid 350301031)
81. C Yu. Y Chen, G. Cline, D Zhang. H Zong, Y Wang. R Bergeron, J. Kim, S. Cushman, G. Cooney, B Atcheson. M F White, E. Kraegen, G I Shulman: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277, 50230-50236 (2002) (Pubitemid 36042170)
82. F Kim. K A Tysseling, J Rice. M Pham, L Haji. B M Gallis, A. Baas, P Paramsothy. C M Giachelli, M. Corson, E W Raines: Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol 25, 989-994 (2005) (Pubitemid 40627844)
83. X Du. D Edelstein, S Obici. N Higham, M. Zou, M Brownlee: Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest 116, 1071-1080 (2006)
84. Y. Kim, G. Shulman, B B Kahn: Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda/zeta but not on glycogen synthase kinase-3. J Biol Chem 277, 32915-32922 (2002) (Pubitemid 34984805)
85. P. Piatti, L. Monti, M Conti. L Baruffaldi, L Galli. C V Phan, B Guazzini. A E Pontiroli, G Pozza: Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 45, 316-321 (1996) (Pubitemid 26069045)
86. L. Monti, E Setola. G Fragasso, R. Camisasca, P Lucotti. E Galluccio, A Origgi. A Margonato, P Piatti: Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy. Am J Physiol Endocrinol Metab 290, E54-E59 (2006)
87. H Wang. H Tan, F Yang: Mechanisms in homocysteine-induced vascular disease. Drug Discovery Today: Disease Mechanisms 2, 25-31 (2005)
88. J. Tsai, H Wang. M A Perrella, M Yoshizumi. N E Sibinga, L. Tan, E Haber. T H Chang, R Schlegel, M E Lee: Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97, 146-153 (1996) (Pubitemid 26021705)
89. M. Lee, H Wang: Homocysteine and Hypomethylation: A Novel Link to Vascular Disease. Trends in Cardiovascular Medicine 9, 49-54 (1999) (Pubitemid 29142580)
90. N Tyagi. K C Sedoris, M Steed. A V Ovechkin, K. Moshal, S C Tyagi: Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289, H2649-H2656 (2005) (Pubitemid 41699830)
91. M Oron-Herman. T Rosenthal, B A Sela: Hyperhomocysteinemia as a component of syndrome X. Metabolism 52, 1491-1495 (2003) (Pubitemid 37461120)
92. E Okada. K Oida, H Tada. K Asazuma, K Eguchi. G Tohda, S Kosaka. S Takahashi, I Miyamori: Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 22, 484-490 (1999) (Pubitemid 29106909)
93. V Sanchez-Margalet. M Valle, F. Ruz, F Gascon. J Mateo, R Goberna: Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 13, 75-79 (2002) (Pubitemid 34082701)
94. J. Meigs, P. Jacques, J Selhub. D E Singer, D. Nathan, N Rifai. R B D'Agostino, Sr., P W Wilson: Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 24, 1403-1410 (2001) (Pubitemid 33716428)
95. E. Giltay, E. Hoogeveen, J. Elbers, L. Gooren, H Asscheman, C D Stehouwer: Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 139, 197-198 (1998) (Pubitemid 28341883)
96. E Setola. L D Monti, E Galluccio. A Palloshi, G Fragasso. R Paroni, F Magni. E P Sandoli, P Lucotti. S Costa, I Fermo. M Galli-Kienle, A Origgi. A Margonato, P Piatti: Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151, 483-489 (2004) (Pubitemid 39430267)
97. S Najib, V Sanchez-Margalet: Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 27, 85-91 (2001) (Pubitemid 32771460)
98. S Najib, V Sanchez-Margalet: Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. J Mol Endocrinol 34, 119-126 (2005) (Pubitemid 40305554)
99. R. Jacobs, J. House, M. Brosnan, J T Brosnan: Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 47, 1967-1970 (1998) (Pubitemid 28549207)
100. A Dicker-Brown. V A Fonseca, L. Fink, P A Kern: The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes. Atherosclerosis 158, 297-301 (2001) (Pubitemid 32913638)
101. V Fonseca. A Dicker-Brown, S Ranganathan. W Song, R. Barnard, L Fink, P A Kern: Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 49, 736-741 (2000) (Pubitemid 30354580)
102. R Ross: Atherosclerosis-an inflammatory disease. N Engl J Med 340, 115-126 (1999)
103. R. Bar, J. Hoak, M L Peacock: Insulin receptors in human endothelial cells: identification and characterization. J Clin Endocrinol Metab 47, 699-702 (1978) (Pubitemid 9010433)
104. M Montagnani, M J Quon: Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2, 285-292 (2000) (Pubitemid 33072197)
105. G Zeng. F H Nystrom, L. Ravichandran, L. Cong, M Kirby. H Mostowski, M J Quon: Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101, 1539-1545 (2000) (Pubitemid 30180890)
106. M Montagnani. H Chen, V. Barr, M J Quon: Insulinstimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser (1179). J Biol Chem 276, 30392-30398 (2001)
107. N. Hartell, H. Archer, C J Bailey: Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochem Pharmacol 69, 781-790 (2005) (Pubitemid 40248620)
108. H Zhang. Y Park, C Zhang: Coronary and aortic endothelial function affected by feedback between adiponectin and tumor necrosis factor alpha in type 2 diabetic mice. Arterioscler Thromb Vasc Biol 30, 2156-21563 (2010)
109. R Ouedraogo. X Wu, S. Xu, L Fuchsel. H Motoshima, K Mahadev. K Hough, R Scalia, B J Goldstein: Adiponectin suppression of high-glucoseinduced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55, 1840-18406 (2006)
110. C Nacci. M Tarquinio, M Montagnani: Molecular and clinical aspects of endothelial dysfunction in diabetes. Intern Emerg Med 4, 107-116 (2009)
111. S. Wheatcroft, I. Williams, A. Shah, M T Kearney: Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20, 255-268 (2003) (Pubitemid 36606117)
112. M. Potenza, F. Marasciulo, M Tarquinio. M J Quon, M Montagnani: Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance. Diabetes 55, 3594-35603 (2006)
113. M Montagnani. I Golovchenko, I Kim. G Y Koh, M. Goalstone, A. Mundhekar, M Johansen. D F Kucik, M. Quon, B Draznin: Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 277, 1794-1799 (2002) (Pubitemid 34968751)
114. M. Goalstone, K Wall. J W Leitner, T Kurowski. N Ruderman, S. Pan, J. Ivy, D. Moller, B Draznin: Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals. Diabetologia 42, 310-316 (1999) (Pubitemid 29111437)
115. B Draznin. P Miles, Y Kruszynska. J Olefsky, J Friedman. I Golovchenko, R Stjernholm. K Wall, M Reitman. D Accili, R Cooksey. D McClain, M Goalstone: Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. Endocrinology 141, 1310-1316 (2000) (Pubitemid 32269097)
116. G. King, S. Buzney, C. Kahn, N Hetu. S Buchwald, S. Macdonald, L I Rand: Differential responsiveness to insulin of endothelial and support cells from micro-and macrovessels. J Clin Invest 71, 974-979 (1983) (Pubitemid 13163270)
117. K. Bornfeldt, R. Gidlof, A Wasteson. M Lake, A Skottner, H J Arnqvist: Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34, 307-313 (1991)
118. I Jialal. M Crettaz, H. Hachiya, C. Kahn, A. Moses, S. Buzney, G L King: Characterization of the receptors for insulin and the insulin-like growth factors on micro-and macrovascular tissues. Endocrinology 117, 1222-1229 (1985) (Pubitemid 15020055)
119. A Klip. T Tsakiridis, A Marette, P A Ortiz: Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. Faseb J 8, 43-53 (1994) (Pubitemid 24047410)
120. C. Wang, I Gurevich, B Draznin: Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 52, 2562-2569 (2003) (Pubitemid 37210546)
121. X. Xi, K Graf. S Goetze, W. Hsueh, R E Law: Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett 417, 283-286 (1997) (Pubitemid 27511605)
122. N Begum. L Ragolia, J Rienzie. M McCarthy, N Duddy: Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension. J Biol Chem 273, 25164-25170 (1998) (Pubitemid 28443276)
123. M Trovati. P Massucco, L Mattiello. C Costamagna, E Aldieri. F Cavalot, G Anfossi. A Bosia, D Ghigo: Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3':5'-cyclic monophosphate and adenosine 3':5'-cyclic monophosphate concentrations. Diabetologia 42, 831-839 (1999) (Pubitemid 29325073)
124. H. Steinberg, H Chaker. R Leaming, A Johnson. G Brechtel, A D Baron: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97, 2601-2610 (1996)
125. C. Tabit, W. Chung, N. Hamburg, J A Vita: Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord 11, 61-74 (2010)
126. K Cusi. K Maezono, A Osman. M Pendergrass, M. Patti, T Pratipanawatr. R A DeFronzo, C. Kahn, L J Mandarino: Insulin resistance differentially affects the PI 3-kinase-and MAP kinase-mediated signaling in human muscle. J Clin Invest 105, 311-320 (2000) (Pubitemid 30094451)
127. J. Kim, M Montagnani. K K Koh, M J Quon: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888-1904 (2006) (Pubitemid 43739401)
128. A. Baron, H. Steinberg, H Chaker. R Leaming, A Johnson, G Brechtel: Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96, 786-792 (1995)
129. D Vicent. J Ilany, T Kondo. K Naruse, S. Fisher, Y. Kisanuki, S Bursell. M Yanagisawa, G. King, C R Kahn: The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111, 1373-1380 (2003) (Pubitemid 36554708)
130. E. Duncan, P. Crossey, S Walker. N Anilkumar, L Poston. G Douglas, V. Ezzat, S. Wheatcroft, A. Shah, M T Kearney: Effect of endothelium-specific insulin resistance on endothelial function in vivo. Diabetes 57, 3307-3314 (2008)
131. C Rask-Madsen. Q Li, B Freund. D Feather, R Abramov. I H Wu, K Chen. J Yamamoto-Hiraoka, J Goldenbogen. K B Sotiropoulos, A Clermont. P Geraldes, C Dall'Osso. A J Wagers, P. Huang, M Rekhter. R Scalia, C. Kahn, G L King: Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 11, 379-389 (2010)
132. R. Shankar, Y Wu. H Q Shen, J. Zhu, A D Baron: Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabete 49, 684-687 (2000) (Pubitemid 30339980)
133. S Czernichow. J R Greenfield, P Galan. F Jellouli, M. Safar, J Blacher. S Hercberg, B I Levy: Macrovascular and microvascular dysfunction in the metabolic syndrome. Hypertens Res 33, 293-7 (2010)
134. K. Ramana, B Friedrich. S Srivastava, A Bhatnagar, S K Srivastava: Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53, 2910-2920 (2004) (Pubitemid 39425917)
135. L. Suzuki, M Poot. R G Gerrity, K E Bornfeldt: Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 50, 851-860 (2001) (Pubitemid 32242644)
136. H Fukumoto. Z Naito, G Asano, T Aramaki: Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus. J Atheroscler Thromb 5, 29-35 (1998)
137. S Uemura. H Matsushita, W Li. A J Glassford, T Asagami. K H Lee, D. Harrison, P S Tsao: Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88, 1291-1298 (2001) (Pubitemid 32587846)
138. S Han. C P Liang, T DeVries-Seimon. M Ranalletta, C. Welch, K Collins-Fletcher. D Accili, I Tabas, A R Tall: Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab 3, 257-266 (2006)
139. C. Liang, S Han. H Okamoto, R Carnemolla. I Tabas, D Accili, A R Tall: Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 113, 764-773 (2004) (Pubitemid 38544170)
140. M. Welham, H Bone. M Levings, L Learmonth. L M Wang, K. Leslie, J. Pierce, J W Schrader: Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem 272, 1377-1381 (1997) (Pubitemid 27034643)
141. R. Bar, P Gorden. J Roth, C. Kahn, P De Meyts: Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of
142. S Bjorkerud, B Bjorkerud: Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 149, 367-380 (1996) (Pubitemid 26256326)
143. L Hegyi. S J Hardwick, M. Mitchinson, J N Skepper: The presence of apoptotic cells in human atherosclerotic lesions. Am J Pathol 150, 371-373 (1997)
144. M. Kockx, A G Herman: Apoptosis in atherogenesis: implications for plaque destabilization. Eur Heart J 19 Suppl G, G23-G28 (1998) (Pubitemid 28321430)
145. K. Iida, H Suzuki. H Sone, H Shimano. H Toyoshima, S Yatoh. T Asano, Y Okuda, N Yamada: Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 22, 380-386 (2002) (Pubitemid 34218742)
146. J H Helderman: Acute regulation of human lymphocyte insulin receptors. Analysis by the glucose clamp. J Clin Invest 74, 1428-1435 (1984)
147. F. Stentz, A E Kitabchi: De novo emergence of growth factor receptors in activated human CD4+ and CD8+ T lymphocytes. Metabolism 53, 117-122 (2004) (Pubitemid 38071946)
148. J H Helderman: Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. J Clin Invest 67, 1636-1642 (1981) (Pubitemid 11127553)
149. J Masuyama. J S Berman, W. Cruikshank, C Morimoto, D M Center: Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol 148, 1367-1374 (1992)
150. D Walcher. M Aleksic, V Jerg. V Hombach, A Zieske. S Homma, J Strong, N Marx: C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 53, 1664-1670 (2004) (Pubitemid 38857022)
151. G Howard. D H O'Leary, D Zaccaro. S Haffner, M Rewers. R Hamman, J. Selby, M. Saad, P Savage, R Bergman: Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93, 1809-1817 (1996)
152. J Danesh. P Whincup, M Walker. L Lennon, A Thomson. P Appleby, J. Gallimore, M B Pepys: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Bmj 321, 199-204 (2000) (Pubitemid 30459555)
153. J. Pickup, M A Crook: Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41, 1241-1248 (1998) (Pubitemid 28449093)
154. A Festa. R D'Agostino, Jr., G Howard. L Mykkanen, R. Tracy, S M Haffner: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102, 42-47 (2000) (Pubitemid 30430551)
155. P Theuma, V A Fonseca: Inflammation, insulin resistance, and atherosclerosis. Metab Syndr Relat Disord 2, 105-113 (2004) (Pubitemid 39545407)
156. J. Dickhout, S Basseri, R C Austin: Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the ugly. Arterioscler Thromb Vasc Biol 28, 1413-1415 (2008)
157. P Libby: Inflammation in atherosclerosis. Nature 420, 868-874 (2002) (Pubitemid 36019640)
158. J. Meigs, F. Hu, N Rifai, J E Manson: Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. Jama 291, 1978-1986 (2004) (Pubitemid 38544279)
159. Y Song. J E Manson, L Tinker. N Rifai, N. Cook, F. Hu, G. Hotamisligil, P. Ridker, B. Rodriguez, K. Margolis, A Oberman, S Liu: Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 56, 1898-1904 (2007) (Pubitemid 47025455)
160. S. Shoelson, J Lee, A B Goldfine: Inflammation and insulin resistance. J Clin Invest 116, 1793-1801 (2006) (Pubitemid 44033299)
161. F Kim. B Gallis, M A Corson: TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am J Physiol Cell Physiol 280, C1057-C1065 (2001)
162. A Bierhaus. S Schiekofer, M Schwaninger. M Andrassy, P. Humpert, J Chen. M Hong, T Luther. T Henle, I Kloting. M Morcos, M Hofmann. H Tritschler, B Weigle. M Kasper, M Smith. G Perry, A. Schmidt, D. Stern, H. Haring, E Schleicher, P P Nawroth: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50, 2792-2808 (2001) (Pubitemid 33733131)
163. M. Read, M. Whitley, A. Williams, T Collins: NFkappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 179, 503-512 (1994)
164. M Yuan. N Konstantopoulos, J Lee. L Hansen, Z. Li, M Karin, S E Shoelson: Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677 (2001) (Pubitemid 32807849)
165. F Kim. M Pham, E Maloney. N O Rizzo, G. Morton, B. Wisse, E. Kirk, A Chait, M W Schwartz: Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28, 1982-1988 (2008)